Secretion of IL-8, which was uniformly downregulated in all tested melanoma cell lines in response to vemurafenib and trametinib in SCM [17], was also reduced by drugs in the medium containing other combinations of growth factors (S5 Fig). This evidence concerns the gene CXCL8 and melanoma.